Laura Comerma

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Manual, digital, and AI tumour-infiltrating lymphocyte scoring: a secondary analysis of the APHINITY randomised trial.

Manual, digital, and AI tumour-infiltrating lymphocyte scoring: a secondary analysis of the APHINITY randomised trial.

Journal: The Lancet. Oncology

Published: January 19, 2026

Estrogen receptor signaling drives immune evasion and immunotherapy resistance in HR+ breast cancer.

Estrogen receptor signaling drives immune evasion and immunotherapy resistance in HR+ breast cancer.

Journal: The Journal of clinical investigation

Published: March 07, 2025

Human Leukocyte Antigen Class I Expression and Natural Killer Cell Infiltration and Its Correlation with Prognostic Features in Luminal Breast Cancers.

Human Leukocyte Antigen Class I Expression and Natural Killer Cell Infiltration and Its Correlation with Prognostic Features in Luminal Breast Cancers.

Journal: Breast cancer (Dove Medical Press)

Published: May 17, 2024

An update on multimodal imaging strategies for nipple discharge: from detection to decision.

An update on multimodal imaging strategies for nipple discharge: from detection to decision.

Journal: Insights into imaging

Published: May 13, 2024

TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak.

TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak.

Journal: Cancer cell

Published: April 17, 2024

P53 expression correlates with low axillary tumor burden in breast cancer.

P53 expression correlates with low axillary tumor burden in breast cancer.

Journal: Breast disease

Published: December 25, 2023

NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer.

NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 07, 2023

Characterization and spatial distribution of the immune cell infiltrate in triple-negative breast cancer: a novel classification based on plasma cells and CD8+ T cells.

Characterization and spatial distribution of the immune cell infiltrate in triple-negative breast cancer: a novel classification based on plasma cells and CD8+ T cells.

Journal: Human pathology

Published: June 23, 2023

Automated quantification of stromal tumour infiltrating lymphocytes is associated with prognosis in breast cancer.

Automated quantification of stromal tumour infiltrating lymphocytes is associated with prognosis in breast cancer.

Journal: Virchows Archiv : an international journal of pathology

Published: April 25, 2023

Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing.

Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing.

Journal: Nature communications

Published: January 26, 2023

Immunomolecular and reactivity landscapes of gut IgA subclasses in homeostasis and inflammatory bowel disease.

Immunomolecular and reactivity landscapes of gut IgA subclasses in homeostasis and inflammatory bowel disease.

Journal: The Journal of experimental medicine

Published: January 12, 2023

Pre-existing tumor host immunity characterization in resected non-small cell lung cancer.

Pre-existing tumor host immunity characterization in resected non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 21, 2022

Showing 1-12 of 34

Last Updated: 09/26/2026